Thromboembolism Flashcards

(33 cards)

1
Q

When would a VTE be considered hospital-acquired?

A

If it occurs within 90 days of hospital admission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Risk factors for VTE

A

Surgery
Trauma
Significant immobility e.g., hospitalisation or long haul flight
Malignancy
Obesity
Pregnancy and postpartum period
Hormonal therapy (COC or HRT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Symptoms of DVT

A

Swelling
Hot to touch
Painful
One leg
Unilateral localised pain
If DVT dislodged can lead to PE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Symptoms of PE

A

SOB
Coughing
Chest pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Diagnostic test for VTE

A

D-dimer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

VTE prophylaxis

A

Mechanical - compression stockings
Pharmacological

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Within how many hours of admission should pharmacological VTE prophylaxis be started?

A

14 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What VTE prophylaxis is used in a general / orthopaedic surgical patient?

A

Mechanical
Pharmacological with LMWH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which pharmacological VTE prophylaxis is preferred in patients with renal impairment?

A

Unfractionated heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which pharmacological VTE prophylaxis is preferred in patients at high risk of bleeding and why?

A

Unfractionated heparin
Shorter half-life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which pharmacological VTE prophylaxis is preferred in patients with lower limb immobilisation (knee replacement) or pelvis fragility fractures, or cardiac / bariatric surgery?

A

Fondaparinux sodium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

For how long after surgery is pharmacological therapy generally continued?

A

At least 7 days or until sufficient mobility has been reestablished

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

For how long after cancer surgery in the abdomen should VTE prophylaxis be continued?

A

28 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

For how long after spinal or cranial surgery should VTE prophylaxis be continued?

A

30 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

For how long after elective hip replacement surgery should VTE prophylaxis be continued? Which drugs are used?

A

LMWH for 10 days then low-dose aspirin for 28 days
LMWH for 28 days in combination with stockings until discharge
Rivaroxaban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

For how long after elective knee replacement surgery should VTE prophylaxis be continued? Which drugs are used?

A

75mg aspirin for 14 days
LMWH for 14 days in + stockings until discharge
Rivaroxaban
Apixaban or Dabigatran can be considered as alternatives

17
Q

VTE prophylaxis for general medical patients

A

LMWH min 7 days
Fondaparinux min 7 days
Renal impairment = unfractionated heparin

18
Q

VTE prophylaxis in acute stroke patients

A

Mechanical stockings - started within 3 days and continued for 30 days post stroke or until sufficiently mobile

19
Q

VTE prophylaxis in pregnancy (duration and risk factors)

A

Women who have given birth, had a miscarriage or termination of pregnancy during the past 6 weeks - start LMWH within 4-8 hours and continued for a min of 7 days

Continued until there is no longer VTE risk or until discharge

Additional mechanical prophylaxis if immobilised until sufficiently mobile or discharged from hospital

20
Q

Baseline blood tests when starting anticoagulation treatment

A

FBC
Renal function
Hepatic function
Coagulation screening - Prothrombin time

21
Q

Treatment of confirmed proximal DVT or PE

A

1st: Apixaban or Rivaroxaban
2nd: LMWH for at least 5 days followed by Dabigatran or Edoxaban
3rd: LMWH and warfarin for at least 5 days or until INR is 2.0 for 2 consecutive readings then warfarin by itself

22
Q

Treatment of confirmed proximal DVT or PE with renal impairment (CrCl 15-50ml/min)

A

1st: Apixaban or Rivaroxaban
2nd: LMWH for at least 5 days followed by Dabigatran (if CrCl >30ml/min) or Edoxaban
3rd: LMWH or unfractionated heparin and warfarin for at least 5 days or until INR is 2.0 for 2 consecutive readings then warfarin by itself

23
Q

Duration of confirmed proximal DVT or PE treatment

A

Min. 3 months

24
Q

Duration of confirmed provoked DVT or PE treatment

A

Consider stopping at 3 months if the provoking factor is no longer present

25
Duration of confirmed proximal/provoked DVT or PE treatment in patients with active cancer
3-6 months
26
Duration of confirmed unprovoked DVT or PE treatment
>3 months
27
Duration of confirmed unprovoked DVT or PE treatment in patients with active cancer
6 months
28
Bleeding risk tools
ORBIT HASBLED
29
Patient factors to exclude continuing treatment with an anticoagulant?
Provoked DVT/PE Renal impairment Active cancer Extreme bodyweight
30
Management if current treatment is not well tolerated
Switch to apixaban Consider aspirin for those who decline anticoagulation
31
Duration of treatment for distal CVT in calf
6 weeks
32
Treatment of confirmed DVT/PE in pregnant women
LMWH Unfractionated heparin if at high risk of haemorrhage
33
Heparin antidote
Protamine sulfate